CoChat

Central Regulation of Glucose Production May Be Impaired in Type 2 Diabetes

Open access
Esterson, Yonah B., Carey, Michelle, Boucai, Laura, Goyal, Akankasha, Raghavan, Pooja, Zhang, Kehao, Mehta, Deeksha, Feng, Daorong, Wu, Licheng, Kehlenbrink, Sylvia, Koppaka, Sudha, Kishore, Preeti, Hawkins, Meredith · 2016 · Diabetes
Cited by 17

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

The challenges of achieving optimal glycemic control in type 2 diabetes highlight the need for new therapies. Inappropriately elevated endogenous glucose production (EGP) is the main source of hyperglycemia in type 2 diabetes. Because activation of central ATP-sensitive potassium (KATP) channels suppresses EGP in nondiabetic rodents and humans, this study examined whether type 2 diabetic humans and rodents retain central regulation of EGP. The KATP channel activator diazoxide was administered in a randomized, placebo-controlled crossover design to eight type 2 diabetic subjects and seven age- and BMI-matched healthy control subjects. Comprehensive measures of glucose turnover and insulin sensitivity were performed during euglycemic pancreatic clamp studies following diazoxide and placebo administration. Complementary rodent clamp studies were performed in Zucker Diabetic Fatty rats. In type 2 diabetic subjects, extrapancreatic KATP channel activation with diazoxide under fixed hormonal conditions failed to suppress EGP, whereas matched control subjects demonstrated a 27% reduction in EGP (P = 0.002) with diazoxide. Diazoxide also failed to suppress EGP in diabetic rats. These results suggest that suppression of EGP by central KATP channel activation may be lost in type 2 diabetes. Restoration of central regulation of glucose metabolism could be a promising therapeutic target to reduce hyperglycemia in type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db15-1465

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Hypothalamic insulin signaling is required for inhibition of glucose production

    Obici, S., Zhang, B. B., Karkanias, G., & Rossetti, L. (2002) · Nature Medicine · doi:10.1038/nm1202-798 · Cited by 904 · cited 1×

    “Several rodent studies have demonstrated that the CNS is involved in the regulation of glucose metabolism through its detection of nutrients and hormones, subsequent signaling through hypothalamic ATP-sensitive potassium (KATP) channels, and transduction of those signals to the liver via vagal efferent fibers (6-14).”
    Background
  • Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity

    Parton, L. E., Ye, C. P., Coppari, R., Enriori, P. J., Choi, B., Zhang, C.-Y., Xu, C., Vianna, C. R., Balthasar, N., Lee, C. E., et al. (2007) · Nature · doi:10.1038/nature06098 · Cited by 700 · cited 2×

    “4 Of note, a number of studies in obese or diabetic rodents have indicated that central sensing mechanisms are ineffective at maintaining glucose homeostasis in these models (17-20).”
    Background
  • Hypothalamic KATP channels control hepatic glucose production

    Pocai, A., Lam, T. K. T., Gutierrez-Juarez, R., Obici, S., Schwartz, G. J., Bryan, J., Aguilar-Bryan, L., & Rossetti, L. (2005) · Nature · doi:10.1038/nature03439 · Cited by 645 · cited 3×

    “This specific protocol was followed, without glucagon infusion, in order to replicate previous studies examining central regulation of glucose production (12,15).”
    BackgroundMethodInfluential
  • Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats

    Spanswick, D., Smith, M. A., Mirshamsi, S., Routh, V. H., & Ashford, M. L. J. (2000) · Nature Neuroscience · doi:10.1038/77660 · Cited by 495 · cited 3×

    “Furthermore, insulin is unable to activate central KATP channels in obese rats (20), consistent with our findings in ZDF rats.”
    BackgroundResult
  • A brain-liver circuit regulates glucose homeostasis

    Pocai, A., Obici, S., Schwartz, G. J., & Rossetti, L. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.11.001 · Cited by 392 · cited 1×

    “Several rodent studies have demonstrated that the CNS is involved in the regulation of glucose metabolism through its detection of nutrients and hormones, subsequent signaling through hypothalamic ATP-sensitive potassium (KATP) channels, and transduction of those signals to the liver via vagal efferent fibers (6-14).”
    Background
  • Regulation of Blood Glucose by Hypothalamic Pyruvate Metabolism

    Lam, T. K. T., Gutierrez-Juarez, R., Pocai, A., & Rossetti, L. (2005) · Science · doi:10.1126/science.1112085 · Cited by 341 · cited 1×

    “Several rodent studies have demonstrated that the CNS is involved in the regulation of glucose metabolism through its detection of nutrients and hormones, subsequent signaling through hypothalamic ATP-sensitive potassium (KATP) channels, and transduction of those signals to the liver via vagal efferent fibers (6-14).”
    Background
  • Regulation of KATP Channel Activity by Diazoxide and MgADP

    Shyng, S.-L., Ferrigni, T., & Nichols, C. G. (1997) · The Journal of General Physiology · doi:10.1085/jgp.110.6.643 · Cited by 282 · cited 1×

    “Furthermore, activation and deactivation of KATP channels are very rapid phenomena (40), making residual activating effects of insulin on KATP channels unlikely.”
    Background
  • Should Depressive Syndromes Be Reclassified as “Metabolic Syndrome Type II”?

    McIntyre, R. S., Soczynska, J. K., Konarski, J. Z., Woldeyohannes, H. O., Law, C. W. Y., Miranda, A., Fulgosi, D., & Kennedy, S. H. (2007) · Annals of Clinical Psychiatry · doi:10.1080/10401230701653377 · Cited by 277 · cited 1×

    “Specifically, these diseases feature impaired systemic glucose metabolism and insulin resistance, as well as poor cerebral glucose utilization, cerebral insulin resistance, cerebral insulin deficiency, and abnormal expression of genes that are typically regulated by insulin (46-49).”
    Background
  • Intraventricular insulin reduces food intake and body weight of lean but not obese zucker rats

    Ikeda, H., West, D. B., Pustek, J. J., Figlewicz, D. P., Greenwood, M. R. C., Porte, D., & Woods, S. C. (1986) · Appetite · doi:10.1016/s0195-6663(86)80006-x · Cited by 230 · cited 2×

    “4 Of note, a number of studies in obese or diabetic rodents have indicated that central sensing mechanisms are ineffective at maintaining glucose homeostasis in these models (17-20).”
    Background
  • Intracerebroventricular Leptin Regulates Hepatic but Not Peripheral Glucose Fluxes

    Liu, L., Karkanias, G. B., Morales, J. C., Hawkins, M., Barzilai, N., Wang, J., & Rossetti, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31160 · Cited by 222 · cited 1×

    “Several rodent studies have demonstrated that the CNS is involved in the regulation of glucose metabolism through its detection of nutrients and hormones, subsequent signaling through hypothalamic ATP-sensitive potassium (KATP) channels, and transduction of those signals to the liver via vagal efferent fibers (6-14).”
    BackgroundSelf-citation

Show all 14 references

Cited by

Metadata

Authors
Esterson, Y. B., Carey, M., Boucai, L., Goyal, A., Raghavan, P., Zhang, K., Mehta, D., Feng, D., Wu, L., Kehlenbrink, S., Koppaka, S., Kishore, P., & Hawkins, M.
Venue
Diabetes
Published
2016-05-10
Volume
65
Issue
9
Pages
2569-2579
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2361358521
Cited by
17
References
14
FWCI
1.66
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.